Gland Pharma to continue to focus on growth in injectable space: Srinivas Sadu
Gland Pharma is in active discussions with companies on vaccine manufacturing front, says Srinivas Sadu, MD & CEO, Gland Pharma.
READ MORE:
Other News Videos
'Tough times never last, tough nations do': Ambani seeks fresh RIL momentum after Rs 1.5 lakh cr...
$320 billion danger: Why 70 EM funds still remain underweight on India
RIL AGM 2026: Date, Time & 4 Big Things to Watch (Jio IPO, Retail, Energy)
SpaceX IPO LIVE | Elon Musk becomes world's first trillionaire as company makes historic debut
SEBI unveils Pilot DLT tokenisation project as risk evaluation process continues